Aethlon Medical Inc (AEMD): שווי שוק להכנסות

The growth of Aethlon Medical (AEMD) is fundamentally driven by macro resilience and dependence on the FDA rather than the broader economy. This P/S ratio chart from GURU.Markets confirms this, with the current parameter standing at 9.60. Management is leading development by implementing the Hemopurifier to combat infections. A stable moat is provided by a unique exosome filter and stringent regulatory barriers within the medtech sector.

High patent barriers and FDA compliance for Aethlon Medical (AEMD) hemosorption cartridges create unique market value, which the current P/S ratio aligns with actual sales volume. This multiple, by dividing market capitalization by annual revenue, allows an investor to determine a fair valuation range for the asset and identify the risk of a fundamental loss of position should the indicator remain at historical lows for a prolonged period.